Cardlytics, Inc. (NASDAQ:CDLX) Given Average Rating of “Hold” by Brokerages

Shares of Cardlytics, Inc. (NASDAQ:CDLX) have received a consensus recommendation of “Hold” from the seven analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $6.92.

Several brokerages have issued reports on CDLX. Evercore ISI started coverage on shares of Cardlytics in a research note on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target on the stock. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday, November 7th.

Insider Buying and Selling at Cardlytics

In related news, CFO Alexis Desieno sold 25,118 shares of the stock in a transaction on Friday, November 15th. The stock was sold at an average price of $3.43, for a total value of $86,154.74. Following the sale, the chief financial officer now owns 116,481 shares in the company, valued at approximately $399,529.83. This represents a 17.74 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Amit Gupta sold 22,607 shares of Cardlytics stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now directly owns 178,519 shares of the company’s stock, valued at approximately $687,298.15. This trade represents a 11.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 69,007 shares of company stock worth $251,297 over the last 90 days. Company insiders own 4.40% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Atom Investors LP acquired a new position in shares of Cardlytics in the third quarter valued at approximately $33,000. XTX Topco Ltd acquired a new position in Cardlytics in the 2nd quarter valued at $107,000. SG Americas Securities LLC bought a new position in Cardlytics during the 3rd quarter worth $45,000. Intech Investment Management LLC acquired a new stake in shares of Cardlytics during the third quarter worth $47,000. Finally, Quest Partners LLC lifted its holdings in shares of Cardlytics by 160.4% during the second quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock worth $147,000 after buying an additional 11,061 shares in the last quarter. 68.10% of the stock is owned by institutional investors.

Cardlytics Price Performance

CDLX stock opened at $3.13 on Friday. The stock has a market cap of $159.07 million, a PE ratio of -0.51 and a beta of 1.53. The stock has a 50-day moving average price of $3.85 and a two-hundred day moving average price of $4.70. Cardlytics has a 1 year low of $2.89 and a 1 year high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40.

Cardlytics (NASDAQ:CDLX) last announced its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The business had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. During the same quarter last year, the firm earned ($0.26) EPS. Cardlytics’s revenue for the quarter was down 15.1% compared to the same quarter last year. Equities analysts forecast that Cardlytics will post -1.52 EPS for the current fiscal year.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.